GlassScriptPhysician profile
Brian J Wheatley
NPI 1114149770
$2,303.26
in general payments reported to CMS, 2019-2025
11 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $88.81 · 2021: $221 · 2022: $67.73 · 2023: $740 · 2024: $295 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,410 · Travel and Lodging: $80.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.23 |
| Travel and Lodging | $80.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,532.93 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis, Gore Propaten Vascular Graft |
| Medtronic, INC. | $169.18 | 2021-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Endurant Iis |
| Endologix LLC | $116.34 | 2021 | |
| Penumbra, INC. | $113.09 | 2025 | Penumbra System |
| Boston Scientific Corporation | $110.91 | 2025 | General - Vascular Intervention |
| Cook Medical LLC | $98.35 | 2019 | |
| Ethicon US, LLC | $52.70 | 2023 | Prolene, Monocryl |
| Siemens Medical Solutions USA, INC. | $50.98 | 2023 | Artis Icono Biplane |
| Lemaitre Vascular, INC. | $21.49 | 2024 | Xenosure Biologic Patch |
| Philips North America LLC | $19.22 | 2020 | |
| Organogenesis INC. | $18.07 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Wheatley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.